Paul D Rubin insider trades: BioAge Labs (BIOA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Paul reports to the SEC
Open-market buys and sales
42 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | BIOA | ↓ Sell | 8,820 | $17.81 | $157K | Direct | Apr 3, 2026 (2d) |
| Mar 2, 2026 | BIOA | ↓ Sell | 7,433 | $20.30 | $151K | Direct | Mar 3, 2026 (1d) |
| Feb 2, 2026 | BIOA | ↓ Sell | 7,433 | $18.75 | $139K | Direct | Feb 3, 2026 (1d) |
| Jan 2, 2026 | BIOA | ↓ Sell | 7,433 | $12.85 | $95K | Direct | Jan 6, 2026 (4d) |
| Dec 9, 2025 | BIOA | ↓ Sell | 18,000 | $12.00 | $216K | Direct | Dec 11, 2025 (2d) |
| Dec 4, 2025 | BIOA | ↓ Sell | 68,897 | $10.19 | $702K | Direct | Dec 5, 2025 (1d) |
| Mar 22, 2016 | XOMA | ↓ Sell | 24,194 | $0.78 | $19K | Direct | Mar 22, 2016 (0d) |
| Jul 15, 2015 | XOMA | ↓ Sell | 5,000 | $4.60 | $23K | Direct | Jul 17, 2015 (2d) |
| Jul 10, 2015 | XOMA | ↓ Sell | 33,400 | $4.55 | $152K | Direct | Jul 10, 2015 (0d) |
| May 28, 2015 | XOMA | ↓ Sell | 1,788 | $3.60 | $6K | Direct | Jun 1, 2015 (4d) |
| Mar 23, 2015 | XOMA | ↓ Sell | 32,742 | $3.94 | $129K | Direct | Mar 23, 2015 (0d) |
| Dec 15, 2014 | XOMA | ↓ Sell | 1,600 | $4.63 | $7K | Direct | Dec 16, 2014 (1d) |
| Nov 20, 2014 | XOMA | ↓ Sell | 5,000 | $4.55 | $23K | Direct | Nov 21, 2014 (1d) |
| Oct 28, 2014 | XOMA | ↓ Sell | 5,000 | $4.57 | $23K | Direct | Oct 29, 2014 (1d) |
| Sep 15, 2014 | XOMA | ↓ Sell | 5,000 | $4.59 | $23K | Direct | Sep 16, 2014 (1d) |
| Sep 4, 2014 | XOMA | ↓ Sell | 10,000 | $4.56 | $46K | Direct | Sep 8, 2014 (4d) |
| Aug 18, 2014 | XOMA | ↓ Sell | 26,748 | $4.34 | $116K | Direct | Aug 19, 2014 (1d) |
| Jun 16, 2014 | XOMA | ↓ Sell | 11,580 | $4.54 | $53K | Direct | Jun 18, 2014 (2d) |
| May 28, 2014 | XOMA | ↓ Sell | 1,785 | $4.22 | $8K | Direct | May 29, 2014 (1d) |
| May 13, 2014 | XOMA | ↓ Sell | 10,000 | $3.84 | $38K | Direct | May 15, 2014 (2d) |
| Mar 18, 2014 | XOMA | ↓ Sell | 17,649 | $6.31 | $111K | Direct | Mar 20, 2014 (2d) |
| Feb 18, 2014 | XOMA | ↓ Sell | 6,000 | $7.55 | $45K | Direct | Feb 19, 2014 (1d) |
| Jan 21, 2014 | XOMA | ↓ Sell | 6,000 | $8.27 | $50K | Direct | Jan 23, 2014 (2d) |
| Dec 18, 2013 | XOMA | ↓ Sell | 6,000 | $5.67 | $34K | Direct | Dec 18, 2013 (0d) |
| Nov 27, 2013 | XOMA | ↓ Sell | 4,696 | $4.54 | $21K | Direct | Dec 2, 2013 (5d) |
| Nov 18, 2013 | XOMA | ↓ Sell | 1,304 | $4.08 | $5K | Direct | Nov 19, 2013 (1d) |
| Oct 18, 2013 | XOMA | ↓ Sell | 746 | $4.71 | $4K | Direct | Oct 21, 2013 (3d) |
| Sep 18, 2013 | XOMA | ↓ Sell | 6,000 | $4.53 | $27K | Direct | Sep 19, 2013 (1d) |
| Aug 19, 2013 | XOMA | ↓ Sell | 6,000 | $3.74 | $22K | Direct | Aug 19, 2013 (0d) |
| Aug 14, 2013 | XOMA | ↓ Sell | 10,520 | $3.86 | $41K | Direct | Aug 16, 2013 (2d) |
| Jul 18, 2013 | XOMA | ↓ Sell | 6,000 | $4.71 | $28K | Direct | Jul 19, 2013 (1d) |
| May 29, 2013 | XOMA | ↓ Sell | 1,797 | $4.16 | $7K | Direct | May 29, 2013 (0d) |
| May 20, 2013 | XOMA | ↓ Sell | 785 | $4.16 | $3K | Direct | May 21, 2013 (1d) |
| Mar 19, 2013 | XOMA | ↓ Sell | 6,990 | $3.29 | $23K | Direct | Mar 27, 2013 (8d) |
| Jan 30, 2006 | CRTX | ↓ Sell | 5,000 | $6.54 | $33K | Direct | Jan 30, 2006 (0d) |
| Jan 17, 2006 | CRTX | ↓ Sell | 5,000 | $6.70 | $33K | Direct | Jan 17, 2006 (0d) |
| Jan 3, 2006 | CRTX | ↓ Sell | 5,000 | $7.12 | $36K | Direct | Jan 4, 2006 (1d) |
| Dec 15, 2005 | CRTX | ↓ Sell | 5,000 | $6.72 | $34K | Direct | Dec 16, 2005 (1d) |
| Nov 30, 2005 | CRTX | ↓ Sell | 5,000 | $6.43 | $32K | Direct | Nov 30, 2005 (0d) |
| Nov 15, 2005 | CRTX | ↓ Sell | 5,000 | $6.78 | $34K | Direct | Nov 16, 2005 (1d) |
| Oct 31, 2005 | CRTX | ↓ Sell | 5,000 | $7.01 | $35K | Direct | Oct 31, 2005 (0d) |
| Oct 17, 2005 | CRTX | ↓ Sell | 5,000 | $8.65 | $43K | Direct | Oct 17, 2005 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BIOA insiders
Open-market trades in the last 12 months
About Paul D Rubin's insider trades
Paul D Rubin is Chief Medical Officer at BioAge Labs (BIOA). Since Oct 17, 2005, Paul has reported no open-market purchases and 42 sales worth $2.8M on SEC Form 4. In the last 12 months: 6 sales ($1.5M).
Their filings also include option exercises (41 filings), grants and awards (14 filings), gifts (3 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BIOA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.